MondegarAI
Aldebaran Capital, LLC

Q4 2025 · 13F-HR

Aldebaran Capital, LLCholdings as filed

Filed 2026-02-12 · accession 0001376474-26-000164

$111.5M
Reported value
35
Positions
2025-12-31
Period end
View analyzed profile →PRO

The Brief · Aldebaran Capital, LLC · Q4 2025

AI · grounded in 13F

Aldebaran Capital, LLC established a new position in MOH valued at $2.19M. The fund also initiated a position in 2KZ0 for $507,163 and increased its stake in LLY by 16.05%. Conversely, the fund closed its position in TECK, resulting in a $533,702 reduction. Other trims included OXY and SIRI, both reduced by over 5%.

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
084670702BRK/BBERKSHIRE HATHAWAY INC DEL$20.2M18.1%40,187CommonSOLE
532457108LLYLILLY ELI & CO$9.7M8.70%9,032CommonSOLE
594918104MSFTMICROSOFT CORP$8.8M7.87%18,140CommonSOLE
H11356104BGBUNGE LIMITED$8.4M7.51%93,995CommonSOLE
674599105OXYOCCIDENTAL PETE CORP$6.6M5.89%159,634CommonSOLE
060505104BACBANK AMERICA CORP$5.8M5.19%105,312CommonSOLE
464287473IWSISHARES TR RUS MDCP VAL$5.7M5.08%40,177CommonSOLE
867224107SUSUNCOR ENERGY INC NEW$5.1M4.59%115,311CommonSOLE
166764100CVXCHEVRON CORP NEW$4.0M3.62%26,521CommonSOLE
46625H100JPMJPMORGAN CHASE & CO$3.6M3.26%11,282CommonSOLE
149205106CATOCATO CORP NEW$3.2M2.89%1,042,448CommonSOLE
00461U105ACRSACLARIS THERAPEUTICS INC$2.9M2.58%954,262CommonSOLE
003261104BCIABRDN ETFS$2.8M2.52%144,053CommonSOLE
35671D857FCXFREEPORT-MCMORAN INC$2.5M2.22%48,835CommonSOLE
92343V104VZVERIZON COMMUNICATIONS INC$2.4M2.19%59,948CommonSOLE
03237H101AMLXAMYLYX PHARMACEUTICALS INC$2.4M2.15%198,508CommonSOLE
156431108CENXCENTURY ALUM CO$2.3M2.03%57,700CommonSOLE
60855R100MOHMOLINA HEALTHCARE INC$2.2M1.97%12,651CommonSOLE
829933100SIRISIRIUS XM HOLDINGS INC$2.1M1.91%106,347CommonSOLE
29250N105ENBENBRIDGE INC$1.9M1.72%40,109CommonSOLE
084670108BRK/ABERKSHIRE HATHAWAY INC DEL$1.5M1.35%2CommonSOLE
703343103PATKPATRICK INDS INC$1.5M1.35%13,872CommonSOLE
763165107RELLRICHARDSON ELECTRS LTD$1.3M1.16%118,979CommonSOLE
878972108TECXTECTONIC THERAPEUTIC INC$779,1840.70%37,353CommonSOLE
69353Y103PMVPPMV PHARMACEUTICALS INC$597,4850.54%477,988CommonSOLE
49372L2092KZ0KEZAR LIFE SCIENCES INC$507,1630.45%80,630CommonSOLE
373261056AN2 THEREAPEUTICS INC$429,5180.39%376,770CommonSOLE
26441C105DUKDUKE ENERGY CORP NEW$421,9560.38%3,600CommonSOLE
369604103GEGENERAL ELECTRIC CO$385,3460.35%1,251CommonSOLE
345370860FFORD MTR CO DEL$360,8000.32%27,500CommonSOLE
58844R108MBINMERCHANTS BANCORP IND$344,8580.31%10,125CommonSOLE
04683R106AVIRATEA PHARMACEUTICALS INC$323,1890.29%90,529CommonSOLE
36828A101GEVGE VERNOVA INC$216,9850.19%332CommonSOLE
45175G207IMAIMAGENEBIO INC$131,5830.12%19,070CommonSOLE
68277Q105OKURONKURE THERAPEUTICS INC$119,7240.11%41,284CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.